ContraFect Announces $6.94 Million in Funding from CARB-X to Support Development of Amurin Platform Against All Gram-negative ESKAPE Pathogens

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach